TrialDiabetes care2012

A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes.

Richard M Bergenstal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.